|
SORT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.18856052672345E-12 |
| Normal-vs-Stage2 |
5.07080044620523E-10 |
| Normal-vs-Stage3 |
9.54210044312731E-11 |
| Normal-vs-Stage4 |
3.78090000000553E-05 |
| Stage1-vs-Stage2 |
2.200800E-01 |
| Stage1-vs-Stage3 |
1.236760E-01 |
| Stage1-vs-Stage4 |
4.117400E-01 |
| Stage2-vs-Stage3 |
8.073800E-01 |
| Stage2-vs-Stage4 |
8.798600E-01 |
| Stage3-vs-Stage4 |
9.705400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.68169997108947E-09 |
| Normal-vs-Asian |
1.998630E-04 |
| Caucasian-vs-AfricanAmerican |
8.931800E-02 |
| Caucasian-vs-Asian |
6.382200E-01 |
| AfricanAmerican-vs-Asian |
3.598600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.76049999525796E-08 |
| Male-vs-Female |
3.801600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.69319999635087E-09 |
| Normal-vs-Extreme_Weight |
1.65933933260476E-12 |
| Normal-vs-Obese |
2.44980036256948E-10 |
| Normal-vs-Extreme_Obese |
3.38950000000615E-06 |
| Normal_Weight-vs-Extreme_Weight |
7.522800E-01 |
| Normal_Weight-vs-Obese |
3.665200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.104200E-01 |
| Extreme_Weight-vs-Obese |
4.172200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.079400E-01 |
| Obese-vs-Extreme_Obese |
4.677600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.84959999999435E-06 |
| Normal-vs-Age(41-60Yrs) |
1.13679954338863E-10 |
| Normal-vs-Age(61-80Yrs) |
7.99980082177854E-11 |
| Normal-vs-Age(81-100Yrs) |
6.55099999802289E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.849000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.068400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.686810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.176200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.779800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.565610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.60123042497662E-12 |
| Normal-VS-KIRP CIMP |
3.824700E-04 |
| Normal-VS-Unclassified PRCC |
2.08599999999004E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.830570E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.631800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.082700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.804200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.056200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.752400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96900273863321E-11 |
| Normal-vs-N1 |
1.06459999704711E-08 |
| Normal-vs-N2 |
1.916120E-02 |
| N0-vs-N1 |
6.101000E-01 |
| N0-vs-N2 |
2.361000E-01 |
| N1-vs-N2 |
4.947600E-01 |
|
|
